This website uses cookies to ensure you get the best experience on our website. Privacy Policy
UroToday UroToday
  • Contact
  • Login
  • Sign Up Free
  • Transformative Evidence
    • mCRPC
      • The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
      • PROfound
      • VISION Trial
    • mHSPC
      • ARASENS Trial
    • nmCRPC
      • ARAMIS Trial
    • PSMA PET Imaging
      • CONDOR Trial
      • OSPREY Trial
    • Bladder Cancer
      • Bladder Cancer Detection
  • Centers of Excellence
    • Urologic Oncology
      • Left Group
        • Bladder Cancer
          • Bladder Cancer
            Ashish Kamat, MD
          • Advanced Bladder Cancer
            Petros Grivas, MD
        • Kidney Cancer
          • Advanced Kidney Cancer
            Pedro Barata, MD, MSc
          • Kidney Cancer Today
            Sumanta (Monty) Kumar Pal, MD
            Jaime Landman, MD
      • Prostate Cancer
        • Advanced Prostate Cancer
          Alicia Morgans, MD, MPH
        • CRPC with Bone Metastases
          Rana R. McKay, MD
        • Imaging Center
          Phillip Koo, MD
        • Localized Prostate Cancer
          Matthew R. Cooperberg, MD, MPH
        • mHSPC
          Alicia Morgans, MD, MPH
        • nmCRPC
          Alicia Morgans, MD, MPH
        • PSMA-Targeted Therapy
      • Translational Prostate Cancer
        • Women in Science
          Andrea Miyahira, Ph.D
        • Health Policy
          Andrea Miyahira, Ph.D
      • Upper Tract Urothelial Carcinoma
        • Upper Tract Urothelial Carcinoma
          Sam S. Chang, MD, MBA
      • TESTICULAR, PENILE & RARE GU MALIGNANCIES
        • Testicular, Penile, and Rare GU Malignancies
    • Pelvic Health & Reconstruction
      • Bladder Health
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
        Stephen R. Kraus, MD
      • Urologic Catheters (Includes CAUTI)
        Diane K. Newman, DNP, ANP-BC, FAAN
  • Videos
    • Exclusives
      • Conferences
      • Exclusive Collaborations
      • Independent Education
      • Covid-19
      • The Prostate Cancer Foundation
    • Urologic Oncology
      • Prostate Cancer
      • Bladder Cancer
      • Kidney Cancer
      • Upper Tract Urothelial Tumors
      • Pelvic Health & Reconstruction
      • Endourology
      • Testicular Cancer
      • Health Policy in Urological Diseases
  • Clinical Trials
    • From the Editor
      • Search Clinical Trials
    • Trials in Progress
      • DORA - PCCTC
      • IRONMAN - PCCTC
      • PROMISE - PCCTC
      • SPLASH Trial
      • Oral EPI-7386
  • Articles
    • Urology (benign and malignant)
      • Urologic Oncology
      • Men's Health
      • Endourology & Stones
      • Pediatric Urology
      • COVID-19 and Genitourinary Cancers
    • Pelvic Health
      • Pelvic Health & Reconstruction
  • Conference Coverage
    • Recent Conferences
      • SUO 2022
      • ASCO GU 2023
      • EAU 2023
    • All Conferences
      • View All
  • PCF
  1. UroToday Home
  2. Recent Abstracts
  3. Urologic Oncology

Prostate Cancer

Recent Abstracts
Active surveillance for favorable-risk prostate cancer: Background, patient selection, triggers for intervention, and outcomes - Abstract May 29, 2012
EORTC QLQ-BM22 and QLQ-C30 quality of life scores in patients with painful bone metastases of prostate cancer treated with strontium-89 radionuclide therapy - Abstract May 29, 2012
Recent changes in the clinicopathologic features of Korean men with prostate cancer: A comparison with Western populations - Abstract May 29, 2012
Androgen deprivation therapy in prostate cancer. Indication and systemic consequences - Abstract May 29, 2012
Patterns of prostate-specific antigen (PSA) testing in Australian men: The influence of family history - Abstract May 29, 2012
Cancer overdiagnosis and overtreatment - Abstract May 29, 2012
The role of 5-alpha-reductase inhibitors in active surveillance - Abstract May 29, 2012
Prostate cancer epidemiology in the United States - Abstract May 29, 2012
Q Fever masquerading as prostate cancer metastases - Abstract May 28, 2012
Genetic predictors of fatigue in prostate cancer patients treated with androgen deprivation therapy: Preliminary findings - Abstract May 28, 2012
Value of the hemorrhage exclusion sign on T1-weighted prostate MR images for the detection of prostate cancer - Abstract May 28, 2012
Health economics evaluation of magnetic resonance imaging for the staging of prostate cancer for Austria and Germany - Abstract May 28, 2012
Novel agents for the management of castration-resistant prostate cancer - Abstract May 28, 2012
Overcoming castration resistance in prostate cancer - Abstract May 28, 2012
Analysis of inter-fraction setup errors and organ motion by daily kilovoltage cone beam computed tomography in intensity modulated radiotherapy of prostate cancer - Abstract May 28, 2012
Prostate-specific antigen levels in men aged 70 years and over: Findings from the CHAMP study - Abstract May 28, 2012
Patient knowledge about prostate-specific antigen (PSA) and prostate cancer in Australia - Abstract May 28, 2012
Assessing the risk of lymph node invasion in patients with intermediate risk prostate cancer treated with extended pelvic lymph node dissection. A novel prediction tool - Abstract May 25, 2012
RNASEL study of genetics of prostate cancer and its relation to clinical staging - Abstract May 25, 2012
3.0 T multiparametric prostate MRI using pelvic phased-array coil: Utility for tumor detection prior to biopsy - Abstract May 25, 2012
Page 1141 of 1288
  • Start
  • Prev
  • 1136
  • 1137
  • 1138
  • 1139
  • 1140
  • 1141
  • 1142
  • 1143
  • 1144
  • 1145
  • Next
  • End
  • About UroToday
  • Journals
  • Calendar
  • Editorial and Advertising Guidelines
  • Editors and Contributors
  • FAQs
  • Privacy Policy
  • Terms of Use
Follow UroToday

COPYRIGHT © 2002 - 2023 DIGITAL SCIENCE PRESS, LLC

Login

Login to update email address, newsletter preferences and use bookmarks.

  • Forgot Password?
  • Sign Up Free